Atrial natriuretic peptide and angiotensin II interaction on noradrenaline uptake in the central nervous system

Arch Int Pharmacodyn Ther. 1990 Sep-Oct:307:11-7.

Abstract

The effects of different concentrations of atrial natriuretic peptide and angiotensin II on [3H]-noradrenaline uptake in hypothalamus and medulla oblongata slices incubated in vitro were determined. Atrial natriuretic peptide, in a dose of 100 mM, increased [3H]-noradrenaline uptake in both regions, while 1 microM of angiotensin II had the opposite effect. The ineffective concentration of 1 nM atrial natriuretic peptide reversed the action of 1 microM of angiotensin II on [3H]-noradrenaline uptake, whereas ineffective concentrations of angiotensin II failed to modify atrial natriuretic peptide effects. These results are compatible with the existence of an atrial natriuretic peptide-angiotensin II interaction in the central nervous system and with the hypothesis that some of the hypotensive effects of atrial natriuretic peptide could occur through modulation of an angiotensin-noradrenergic mechanism in the central nervous system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Angiotensin II / pharmacology*
  • Animals
  • Atrial Natriuretic Factor / pharmacology*
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism*
  • Hypothalamus / drug effects
  • Hypothalamus / metabolism
  • In Vitro Techniques
  • Male
  • Medulla Oblongata / drug effects
  • Medulla Oblongata / metabolism
  • Norepinephrine / metabolism*
  • Rats
  • Rats, Inbred Strains

Substances

  • Angiotensin II
  • Atrial Natriuretic Factor
  • Norepinephrine